Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM2 | P31350 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CD44 | P16070 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MITF | O75030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL476574 | 0.84 | MAPT (0.42) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL15928718 | 0.81 | CYP3A4 (0.45) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL9158033 | 0.81 | ALDH1A1 (0.46) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL9158714 | 0.80 | RRM2 (0.38) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL7081554 | 0.79 | CA12 (0.37) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL8930739 | 0.78 | ALDH1A1 (0.40) | RRM2ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL4784858 | 0.77 | ALDH1A1 (0.44) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL7694710 | 0.76 | ALDH1A1 (0.40) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL3380445 | 0.76 | CA12 (0.36) | RRM2CA12CA1CA2CA9 | |
| SCHEMBL5549248 | 0.75 | RRM2 (0.38) | RRM2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9943809-B2 | Solvent resistant thin film composite membrane and its preparation | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-04-17 | — | — | US | claimed |
| US-20170065937-A1 | SOLVENT RESISTANT THIN FILM COMPOSITE MEMBRANE AND ITS PREPARATION | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2017-03-09 | — | — | US | claimed |
| US-12036515-B2 | Thin-film composite membrane and methods of making and using the same | THE PENN STATE RESEARCH FOUNDATION (PA) | 2024-07-16 | — | — | US | disclosed |
| US-20210370240-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION | 2021-12-02 | — | — | US | disclosed |
| EP-3860743-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | The Penn State Research Foundation (US) | 2021-08-11 | — | — | EP | disclosed |
| WO-2020072594-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | THE PENN STATE RESEARCH FOUNDATION (US) | 2020-04-09 | — | — | WO | disclosed |
| WO-2019164977-A1 | FLUORINATED NUCLEOTIDES AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2019-08-29 | — | — | WO | disclosed |
| US-9943809-B2 | Solvent resistant thin film composite membrane and its preparation | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-04-17 | — | — | US | disclosed |
| US-20170065937-A1 | SOLVENT RESISTANT THIN FILM COMPOSITE MEMBRANE AND ITS PREPARATION | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2017-03-09 | — | — | US | disclosed |
| US-7727434-B2 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY (US) | 2010-06-01 | — | — | US | disclosed |
| US-20070039874-A1 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY | 2007-02-22 | — | — | US | disclosed |
| US-5693227-A | POLYMERIZATION OF MOLECULES HAVING ELECTROPHILIC AND NUCLEOPHILIC SUBSTITUENTS ON THE SAME OR DIFFERENT MOLECULES; REGENERATION OF AMINOPYRIDINE CATALYSTS | IONICS, INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| EP-0355364-A2 | 3,5-Diaminophenyl alkyl amines and their use in hair-dyeing compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036515-B2 | Thin-film composite membrane and methods of making and using the same | PORCN, MLEC, FLOT1 | RRM2 3891/4885CA12 1547/4885CA1 2322/4885 |
| US-20210370240-A1 | THIN-FILM COMPOSITE MEMBRANE AND METHODS OF MAKING AND USING THE SAME | PORCN, MLEC, FLOT1 | RRM2 3891/4885CA12 1547/4885CA1 2322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.